About Aristo Biotech
Aristo Biotech is a company based in Vadodara (India) founded in 2005. The company has 53 employees as of March 25, 2025. Aristo Biotech offers products and services including Acetamiprid 20% SP, Glyphosate 41% SL, Hexaconazole 5% EC, Chlormequat Chloride 50% SL, and Cypermethrin 25% EC. Aristo Biotech operates in a competitive market with competitors including Diversey, Modern Synthesis, Reliance Steel & Aluminum, Cupid and VINI International, among others.
- Headquarter Vadodara, India
- Employees 53 as on 25 Mar, 2025
- Stage Public
-
Sectors
Industrial Goods & Manufacturing
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Aristo Bio Tech And Lifescience Limited
-
Annual Revenue
$28.66 M (USD)12.44as on Mar 31, 2024
-
Net Profit
$455.11 K (USD)9.36as on Mar 31, 2024
-
EBITDA
$992.06 K (USD)-2.41as on Mar 31, 2024
-
Latest Funding Round
-
Investors
-
Employee Count
53
as on Mar 25, 2025
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Aristo Biotech
Aristo Biotech is a publicly listed company on the NSE with ticker symbol ARISTO in India, operating in the Process industries sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Aristo Biotech
Aristo Biotech offers a comprehensive portfolio of products and services, including Acetamiprid 20% SP, Glyphosate 41% SL, Hexaconazole 5% EC, Chlormequat Chloride 50% SL, and Cypermethrin 25% EC.
Insecticide for controlling pests on various crops
Herbicide for weed control in agricultural fields
Fungicide to prevent fungal diseases in plants
Regulator to control plant growth and enhance yields
Insecticide for broad-spectrum pest management
Funding Insights of Aristo Biotech
Investments & Acquisitions by Aristo Biotech
Financial Statements - Aristo Biotech
Aristo Biotech Comparisons
Competitors of Aristo Biotech
Aristo Biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Diversey, Modern Synthesis, Reliance Steel & Aluminum, Cupid and VINI International, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Water treatment and hygiene solutions are provided for various industries.
|
|
| domain | founded_year | HQ Location |
Biomaterials are developed via microbial fermentation for diverse applications.
|
|
| domain | founded_year | HQ Location |
Contract manufacturer of chemical, automotive, aircraft, and other products
|
|
| domain | founded_year | HQ Location |
Contract manufacturer of male & female condoms
|
|
| domain | founded_year | HQ Location |
Beauty care products are manufactured through contract services.
|
|
| domain | founded_year | HQ Location |
Actives, advanced intermediates, and specialty chemicals are custom manufactured.
|
Frequently Asked Questions about Aristo Biotech
Aristo Biotech was founded in 2005.
Aristo Biotech is headquartered in Vadodara, India. It is registered at Vadodara, Gujarat, India.
As of Mar 25, 2025, the latest employee count at Aristo Biotech is 53.
Annual revenue of Aristo Biotech is $28.66M as on Mar 31, 2024.
Aristo Biotech was established in 2005 in Vadodara, India, within the media sector. Audio news bulletins on politics, business, sports, and international affairs are produced by a team of journalists and distributed through a network to affiliated radio stations. Customized online radio stations are also created for corporate clients, featuring 247 programming, music licensing, and branding integration. Operations focus on content delivery and tailored audio services.
Aristo Biotech's top competitors include Diversey, Inventys and Modern Synthesis.
Aristo Biotech offers Acetamiprid 20% SP, Glyphosate 41% SL, Hexaconazole 5% EC, Chlormequat Chloride 50% SL, and Cypermethrin 25% EC.
Yes, Aristo Biotech is publicly traded on NSE under the ticker symbol ARISTO.
The ticker symbol of Aristo Biotech is ARISTO on NSE.